Achieve Life Sciences (ACHV) Asset Writedowns and Impairment (2016)
Achieve Life Sciences (ACHV) posted Asset Writedowns and Impairment of $202000.0 for Q4 2016.
Achieve Life Sciences (ACHV) Asset Writedowns and Impairment (2016) Analysis & Trends
Achieve Life Sciences' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $202000.0 for Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Achieve Life Sciences | 327.23 Mn | 327.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 202,000.00 |
| Dec 31, 2016 | 202,000.00 |